Therion Advisers is a small Singapore‑based corporate finance adviser and private investment/advisory firm that advises on strategy, fundraising and business development and selectively invests in early‑stage startups, with a stated focus on climate and longevity-related innovations and leveraging a global network for dealflow and connections[1][5].
High-Level Overview
- Mission: Direct capital for impact without compromising returns—particularly supporting innovations that can reverse climate change and extend human lifespan—while connecting people and ideas via a global network[1].
- Investment philosophy: Selective, founder‑friendly direct investments in early‑stage startups combined with advisory/corporate finance services; emphasis on impact + financial returns and hands‑on deal and network support[1][5].
- Key sectors: Climate tech (decarbonization / climate reversal) and longevity / healthspan, plus fintech and edtech mentioned in partner backgrounds[1][5].
- Impact on the startup ecosystem: Acts as a connector/adviser and small capital provider for early‑stage ventures in niche impact sectors, leveraging partners’ investment banking, asset‑management and entrepreneurship experience to help startups with fundraising, governance and strategic introductions[1][5].
Origin Story
- Founding year & structure: Therion Advisers Pte. Ltd. is registered in Singapore as an exempt corporate finance adviser with the Monetary Authority of Singapore; public materials describe it as a small firm (about two employees in third‑party listings) rather than a large institutional fund[1][2].
- Key partners & backgrounds: The firm’s leadership includes Milena Nikolova (previous UBS investment banking and wealth management experience; independent director roles) and Ivan (surname not shown in the public summary) who is founder/CEO of Kalibra.ai and former hedge fund portfolio manager with roles at GAMA, Algebris Investments and Credit Suisse; both bring decades of finance experience and global networks[1].
- Evolution of focus: From decades of careers in investment banking, asset and wealth management the partners moved to combine advisory services with selective direct investments focused on impact themes (climate, longevity) and leveraging their networks to support founders[1][5].
Core Differentiators
- Boutique, senior‑led advisory + investing: Partners are senior finance professionals who combine corporate finance advisory with selective early‑stage investing, offering boutique, high‑touch support rather than passive capital[1][5].
- Thematic, impact orientation: Explicitly targets climate reversal and longevity/healthspan innovations—sectors with high social impact and specialized technical/market needs[1].
- Network & operating experience: Partners’ backgrounds (investment banking, hedge funds, entrepreneurial CEO of a healthtech startup) provide corporate finance, fundraising and investor access that can accelerate founder outcomes[1].
- Regulated adviser status: Registered as an exempt corporate finance adviser with Singapore’s Monetary Authority, which signals formal regulatory standing for advisory activities in that jurisdiction[1].
Role in the Broader Tech Landscape
- Trends they ride: Increasing investor interest in climate tech and biotechnology/longevity, plus the rise of specialized boutique advisers that pair capital with operational and fundraising support for early‑stage companies[1].
- Why timing matters: Growing policy and capital flows into decarbonization and longevity R&D create opportunity for targeted early investments and advisory services that can help startups scale and access institutional capital[1].
- Market forces in their favor: Tightening focus from institutional and high‑net‑worth investors on impact and deep‑tech, plus demand from founders for informed capital and introductions, benefits firms that offer both advisory and selective direct investing[1][5].
- Influence on ecosystem: As a connector and small investor, Therion can help channel experienced institutional know‑how into early ventures, improving governance, fundraising outcomes and cross‑border introductions in Singapore and beyond[1][5].
Quick Take & Future Outlook
- Near term: Expect continued selective early‑stage investments and advisory mandates in climate and longevity, leveraging partners’ deal experience and operating roles (e.g., founder CEO involvement in healthtech) to generate differentiated dealflow[1].
- Medium term trends that will shape them: Growth in climate tech capital, increasing commercialization of longevity research, and continued demand for boutique advisers that combine regulatory know‑how and investor access[1].
- How their influence may evolve: If they scale a track record of successful exits or high‑profile advisory mandates, Therion could expand from a two‑partner boutique into a recognized sector specialist or seed/angel syndicate in climate and longevity; absent that, they will likely remain a high‑touch adviser and selective investor focused on niche, high‑impact opportunities[1][5].
Notes and limitations
- Public information about Therion Advisers is limited to the firm’s own “About” page and small business directory entries; there is no comprehensive third‑party coverage or a public portfolio list in the sources reviewed, so details about deal-level track record and AUM are not available from these sources[1][2][5].
